SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-054519
Filing Date
2012-10-03
Accepted
2012-10-03 17:03:37
Documents
1
Period of Report
2012-09-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v325024_8k.htm 8-K 16878
  Complete submission text file 0001144204-12-054519.txt   18153
Mailing Address 7600 WISCONSIN AVE. SUITE 750 BETHESDA MD 20814
Business Address 7600 WISCONSIN AVE. SUITE 750 BETHESDA MD 20814 4256083008
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-33393 | Film No.: 121127423
SIC: 2834 Pharmaceutical Preparations